Keywords
To read this article in full you will need to make a payment
Purchase one-time access:
Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online accessOne-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribers receive full online access to your subscription and archive of back issues up to and including 2002.
Content published before 2002 is available via pay-per-view purchase only.
Subscribe:
Subscribe to Clinics in Laboratory MedicineAlready a print subscriber? Claim online access
Already an online subscriber? Sign in
Register: Create an account
Institutional Access: Sign in to ScienceDirect
References
- The use of lithium levels in the emergency department.J Emerg Med. 1999; 17: 887-891
- Drug screening versus history in detection of substance use in ED psychiatric patients.Am J Emerg Med. 2001; 19: 49-51
- Declared and undeclared substance use among emergency department patients: a population-based study.Addiction. 2006; 101: 706-712
- Utility of routine drug screening in a psychiatric emergency setting.Psychiatr Serv. 2000; 51: 474-478
- Screening urine for drugs of abuse in the emergency department: do test results affect physicians' patient care decisions?.CJEM. 2004; 6: 104-111
- Drug screens for psychiatric patients in the emergency department: evaluation and recommendations.Psychosomatics. 2013; 54: 60-66
- Clinical policy: critical issues in the diagnosis and management of the adult psychiatric patient in the emergency department.Ann Emerg Med. 2006; 47: 79-99
- The last half-century of psychiatric services as reflected in psychiatric services.Psychiatr Serv. 2000; 51: 41-67
- Relation of the therapeutic alliance with outcome and other variables: a meta-analytic review.J Consult Clin Psychol. 2000; 68: 438-450
- Compliance with medication regimens for mental and physical disorders.Psychiatr Serv. 1998; 49: 196-201
- Clinical interventions for treatment non-adherence in psychosis: meta-analysis.Br J Psychiatry. 2003; 183: 197-206
- Practice guideline for the treatment of patients with major depressive disorder third edition.Am J Psychiatry. 2010; 167: 1
- Stahl’s essential psychopharmacology. The prescriber’s guide.4th edition. Cambridge University Press, New York2011
- Handbook of psychiatric drug therapy.6th edition. Lippincott Williams & Wilkins Handbook Series, Philadelphia2009
- Pharmacogenetics of antidepressants and antipsychotics: the contribution of allelic variations to the phenotype of drug response.Mol Psychiatry. 2004; 9: 442-473
- Initiation and adaptation: a paradigm for understanding psychotropic drug action.Am J Psychiatry. 1996; 153: 151-162
- How fast are antidepressants?.J Clin Psychiatry. 2000; 61: 712-721
- Tricyclic antidepressant overdose: a review.Emerg Med J. 2001; 18: 236-241
- Long-term efficacy and therapeutic drug monitoring of sertraline in major depression.Hum Psychopharmacol. 2003; 18: 385-388
- Venlafaxine serum levels and CYP2D6 genotype.Ther Drug Monit. 2000; 22: 202-208
- Fluoxetine and norfluoxetine plasma concentrations in major depression: a multicenter study.Am J Psychiatry. 1997; 154: 963-969
- Relationship between plasma level and therapeutic effect of nortriptyline.Br Med J. 1971; 3: 331-334
- Tricyclic antidepressant overdose.JACEP. 1979; 8: 413-425
- Routine therapeutic drug monitoring in patients treated with 10-360 mg/day citalopram.Ther Drug Monit. 2003; 25: 600-608
- Therapeutic drug monitoring of selective serotonin reuptake inhibitors influences clinical dosing strategies and reduces drug costs in depressed elderly patients.Acta Psychiatr Scand. 2000; 101: 354-359
- AGNP consensus guidelines for therapeutic drug monitoring in psychiatry: update 2011.Pharmacopsychiatry. 2011; 44: 195-235
- The molecular neurobiology of depression.Nature. 2008; 455: 894-902
- Screening procedure for detection of antidepressants of the selective serotonin reuptake inhibitor type and their metabolites in urine as part of a modified systematic toxicological analysis procedure using gas chromatography-mass spectrometry.J Anal Toxicol. 2000; 24: 340-347
- Lithium salts in the treatment of psychotic excitement.Med J Aust. 1949; 2: 349-352
- Neural and developmental actions of lithium: a unifying hypothesis.Cell. 1989; 59: 411-419
- Lithium inhibits glycogen synthase kinase-3 activity and mimics wingless signalling in Intact cells.Curr Biol. 1996; 6: 1664-1668
- Comparison of standard and low serum levels of lithium for maintenance treatment of bipolar disorder.N Engl J Med. 1989; 321: 1489-1493
- Efficacy of divalproex vs lithium and placebo in the treatment of mania. The Depakote Mania Study Group.JAMA. 1994; 271: 918-924
- A multicenter, randomized, double-blind, placebo-controlled trial of extended-release carbamazepine capsules as monotherapy for bipolar disorder patients with manic or mixed episodes.J Clin Psychiatry. 2004; 65: 478-484
- A placebo-controlled 18-month trial of lamotrigine and lithium maintenance treatment in recently manic or hypomanic patients with bipolar I disorder.Arch Gen Psychiatry. 2003; 60: 392-400
- Mechanisms of action of second generation antipsychotic drugs in schizophrenia: insights from brain imaging studies.Eur Psychiatry. 2005; 20: 15-27
- Response of patients with treatment-refractory schizophrenia to clozapine within three serum level ranges.Am J Psychiatry. 1996; 153: 1579-1584
- Quantitation of seven low dosage antipsychotic drugs in human post mortem blood using LC-MS-MS.J Anal Toxicol. 2008; 32: 147-155
- Predicting haloperidol occupancy of central dopamine D2 receptors from plasma levels.Psychopharmacology (Berl). 2000; 149: 1-5
- The relationship between serum concentration and therapeutic effect of haloperidol in patients with acute schizophrenia.Clin Pharmacokinet. 1998; 34: 227-263
- Pharmacologic profile of perphenazine’s metabolites.J Clin Psychopharmacol. 2000; 20: 181-187
- Risperidone dose and blood level variability: accumulation effects and interindividual and intraindividual variability in the nonresponder patient in the clinical practice setting.J Clin Psychopharmacol. 1997; 17: 478-484
- Suggested minimal effective dose of risperidone based on PET-measured D2 and 5-HT2A receptor occupancy in schizophrenic patients.Am J Psychiatry. 1999; 156: 869-875
- Cognitive and sedative effects of benzodiazepine use.Curr Pharm Des. 2002; 8: 45-58
- Benzodiazepine use and abuse among patients with severe mental illness and co-occurring substance use disorders.Psychiatr Serv. 2003; 54: 1395-1401
- Therapeutic and toxic blood concentrations of more than 800 drugs and other zenobiotics.Pharmazie. 2003; 58: 447-474
- Pharmacokinetics and bioavailability of intravenous, intramuscular, and oral lorazepam in humans.J Pharm Sci. 1979; 68: 57-63
- Urine drug screening: practical guide for clinicians.Mayo Clin Proc. 2008; 83: 66-76
- Attention-deficit/hyperactivity disorder: a selective overview.Biol Psychiatry. 2005; 57: 1215-1220
- A 14-month randomized clinical trial of treatment strategies for attention-deficit/hyperactivity disorder. The MTA Cooperative Group. Multimodal treatment study of children with ADHD.Arch Gen Psychiatry. 1999; 56: 1073-1086
- Pharmacotherapy of attention-deficit/hyperactivity disorder reduces risk for substance use disorder.Pediatrics. 1999; 104: e20
- Urine drug testing in pain medicine.J Pain Symptom Manage. 2004; 27: 260-267
- Misuse of atypical antipsychotics in conjunction with alcohol and other drugs of abuse.J Subst Abuse Treat. 2015; 48: 8-12
- Intravenous bupropion: a previously undocumented method of abuse of a commonly prescribed antidepressant agent.J Addict Med. 2013; 7: 216-217
- Abuse potential of bupropion nasal insufflation: a case report.J Clin Psychopharmacol. 2009; 29: 618-619
- Do antidepressants have any potential to cause addiction?.J Psychopharmacol. 1999; 13: 300-307
Article info
Publication history
Published online: August 27, 2016
Footnotes
All authors have no financial disclosures.
Identification
Copyright
© 2016 Elsevier Inc. All rights reserved.
